Insider · CIK 0001817209
Geraldine Pannu
Files at RBB (RBB Bancorp), PCSA (Processa Pharmaceuticals, Inc.). First filing Apr 1, 2026, latest Apr 1, 2026.
In brief
Geraldine Pannu files SEC Form 4 as director at PCSA (Processa Pharmaceuticals, Inc.), and also at RBB (RBB Bancorp). Since Apr 1, 2026, Geraldine Pannu has reported 1 open-market buy worth $5,253 and 0 open-market sells worth $0, the latest filed on Apr 1, 2026.
A track record needs three past buys with six months of prices behind them; Geraldine Pannu has 0, so none is measured yet.
The newest scored trade: bought $5,253 of PCSA on Mar 31, 2026, filed Apr 1, 2026, scored 48 (moderate). In the last 12 months: 1 buy worth $5,253 and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PCSA: Processa Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 48Moderate | Processa Pharmaceuticals, Inc. | $5,253 2,072 shares | +1786% | +36% from low-79% from high |
Transactions
Every row this insider has filed, 17 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 26, 2026 | PCSA Processa Pharmaceuticals, Inc. | AGrant or award Restricted Stock Unitsderivative | +33,500 | $0.00 | $0 | 38,749 | Jul 28, 2026 |
| Jun 26, 2026 | PCSA Processa Pharmaceuticals, Inc. | MOption exercise Common Stock | +203 | - | - | 2,391 | Jun 30, 2026 |
| Jun 26, 2026 | PCSA Processa Pharmaceuticals, Inc. | MOption exercise Restricted Stockderivative | -203 | $0.00 | $0 | 5,249 | Jun 30, 2026 |
| May 21, 2026 | RBB RBB Bancorp | MOption exercise Common Stock, No Par Value | +700 | $0.00 | $0 | 6,421 | May 26, 2026 |
| May 21, 2026 | RBB RBB Bancorp | MOption exercise Common Stock, No Par Value | +1,846 | $0.00 | $0 | 8,267 | May 26, 2026 |
| May 21, 2026 | RBB RBB Bancorp | MOption exercise Restricted Stock Unitsderivative | -700 | $0.00 | $0 | 0 | May 26, 2026 |
| May 21, 2026 | RBB RBB Bancorp | AGrant or award Restricted Stock Unitsderivative | +2,546 | $0.00 | $0 | 2,546 | May 26, 2026 |
| May 21, 2026 | RBB RBB Bancorp | MOption exercise Restricted Stock Unitsderivative | -1,846 | $0.00 | $0 | 700 | May 26, 2026 |
| Mar 31, 2026 | PCSA Processa Pharmaceuticals, Inc. | POpen-market purchase Common Stock | +2,072 | $2.54 | $5,253 | 2,188 | Apr 1, 2026 |
| Oct 1, 2025 | PCSA Processa Pharmaceuticals, Inc. | AGrant or award Restricted Stock Unitsderivative | +100,000 | $0.00 | $0 | 100,000 | Oct 3, 2025 |
| Oct 1, 2025 | PCSA Processa Pharmaceuticals, Inc. | AGrant or award Stock Options (Right to Buy)derivative | +300,000 | $0.00 | $0 | 300,000 | Oct 3, 2025 |
| Sep 3, 2024 | PCSA Processa Pharmaceuticals, Inc. | AGrant or award Restricted Stockderivative | +31,206 | $0.00 | $0 | 36,275 | Sep 18, 2025 |
| Jul 24, 2025 | PCSA Processa Pharmaceuticals, Inc. | AGrant or award Restricted Stockderivative | +175,299 | $0.00 | $0 | 206,505 | Jul 28, 2025 |
| May 21, 2025 | RBB RBB Bancorp | MOption exercise Common Stock, No Par Value | +2,821 | $0.00 | $0 | 5,721 | May 22, 2025 |
| May 21, 2025 | RBB RBB Bancorp | MOption exercise Restricted Stock Unitsderivative | -2,821 | $0.00 | $0 | 700 | May 22, 2025 |
| May 15, 2025 | RBB RBB Bancorp | MOption exercise Common Stock, No Par Value | +700 | $0.00 | $0 | 2,900 | May 16, 2025 |
| May 15, 2025 | RBB RBB Bancorp | MOption exercise Restricted Stock Unitsderivative | -700 | $0.00 | $0 | 0 | May 16, 2025 |
Questions about Geraldine Pannu
Answered from the filings on this page, as of the latest one.
Is Geraldine Pannu buying or selling?
In the last 12 months Geraldine Pannu reported 1 open-market buy worth $5,253 and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $5,253 of PCSA on Mar 31, 2026. Grants, option exercises and tax withholding are not counted.
How did Geraldine Pannu's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Geraldine Pannu has 0.
Where does Geraldine Pannu file Form 4?
Geraldine Pannu has filed Form 4 at PCSA (Processa Pharmaceuticals, Inc.); RBB (RBB Bancorp). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.